Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.

IF 20.1 1区 医学 Q1 OBSTETRICS & GYNECOLOGY
Ning Ding, Siobán D Harlow, John F Randolph, Rita Loch-Caruso, Sung Kyun Park
{"title":"Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.","authors":"Ning Ding, Siobán D Harlow, John F Randolph, Rita Loch-Caruso, Sung Kyun Park","doi":"10.1093/humupd/dmaa018","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are found widespread in drinking water, foods, food packaging materials and other consumer products. Several PFAS have been identified as endocrine-disrupting chemicals based on their ability to interfere with normal reproductive function and hormonal signalling. Experimental models and epidemiologic studies suggest that PFAS exposures target the ovary and represent major risks for women's health.</p><p><strong>Objective and rationale: </strong>This review summarises human population and toxicological studies on the association between PFAS exposure and ovarian function.</p><p><strong>Search methods: </strong>A comprehensive review was performed by searching PubMed. Search terms included an extensive list of PFAS and health terms ranging from general keywords (e.g. ovarian, reproductive, follicle, oocyte) to specific keywords (including menarche, menstrual cycle, menopause, primary ovarian insufficiency/premature ovarian failure, steroid hormones), based on the authors' knowledge of the topic and key terms.</p><p><strong>Outcomes: </strong>Clinical evidence demonstrates the presence of PFAS in follicular fluid and their ability to pass through the blood-follicle barrier. Although some studies found no evidence associating PFAS exposure with disruption in ovarian function, numerous epidemiologic studies, mostly with cross-sectional study designs, have identified associations of higher PFAS exposure with later menarche, irregular menstrual cycles, longer cycle length, earlier age of menopause and reduced levels of oestrogens and androgens. Adverse effects of PFAS on ovarian folliculogenesis and steroidogenesis have been confirmed in experimental models. Based on laboratory research findings, PFAS could diminish ovarian reserve and reduce endogenous hormone synthesis through activating peroxisome proliferator-activated receptors, disrupting gap junction intercellular communication between oocyte and granulosa cells, inducing thyroid hormone deficiency, antagonising ovarian enzyme activities involved in ovarian steroidogenesis or inhibiting kisspeptin signalling in the hypothalamus.</p><p><strong>Wider implications: </strong>The published literature supports associations between PFAS exposure and adverse reproductive outcomes; however, the evidence remains insufficient to infer a causal relationship between PFAS exposure and ovarian disorders. Thus, more research is warranted. PFAS are of significant concern because these chemicals are ubiquitous and persistent in the environment and in humans. Moreover, susceptible groups, such as foetuses and pregnant women, may be exposed to harmful combinations of chemicals that include PFAS. However, the role environmental exposures play in reproductive disorders has received little attention by the medical community. To better understand the potential risk of PFAS on human ovarian function, additional experimental studies using PFAS doses equivalent to the exposure levels found in the general human population and mixtures of compounds are required. Prospective investigations in human populations are also warranted to ensure the temporality of PFAS exposure and health endpoints and to minimise the possibility of reverse causality.</p>","PeriodicalId":55045,"journal":{"name":"Human Reproduction Update","volume":"26 5","pages":"724-752"},"PeriodicalIF":20.1000,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5b/86/dmaa018.PMC7456353.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Reproduction Update","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/humupd/dmaa018","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are found widespread in drinking water, foods, food packaging materials and other consumer products. Several PFAS have been identified as endocrine-disrupting chemicals based on their ability to interfere with normal reproductive function and hormonal signalling. Experimental models and epidemiologic studies suggest that PFAS exposures target the ovary and represent major risks for women's health.

Objective and rationale: This review summarises human population and toxicological studies on the association between PFAS exposure and ovarian function.

Search methods: A comprehensive review was performed by searching PubMed. Search terms included an extensive list of PFAS and health terms ranging from general keywords (e.g. ovarian, reproductive, follicle, oocyte) to specific keywords (including menarche, menstrual cycle, menopause, primary ovarian insufficiency/premature ovarian failure, steroid hormones), based on the authors' knowledge of the topic and key terms.

Outcomes: Clinical evidence demonstrates the presence of PFAS in follicular fluid and their ability to pass through the blood-follicle barrier. Although some studies found no evidence associating PFAS exposure with disruption in ovarian function, numerous epidemiologic studies, mostly with cross-sectional study designs, have identified associations of higher PFAS exposure with later menarche, irregular menstrual cycles, longer cycle length, earlier age of menopause and reduced levels of oestrogens and androgens. Adverse effects of PFAS on ovarian folliculogenesis and steroidogenesis have been confirmed in experimental models. Based on laboratory research findings, PFAS could diminish ovarian reserve and reduce endogenous hormone synthesis through activating peroxisome proliferator-activated receptors, disrupting gap junction intercellular communication between oocyte and granulosa cells, inducing thyroid hormone deficiency, antagonising ovarian enzyme activities involved in ovarian steroidogenesis or inhibiting kisspeptin signalling in the hypothalamus.

Wider implications: The published literature supports associations between PFAS exposure and adverse reproductive outcomes; however, the evidence remains insufficient to infer a causal relationship between PFAS exposure and ovarian disorders. Thus, more research is warranted. PFAS are of significant concern because these chemicals are ubiquitous and persistent in the environment and in humans. Moreover, susceptible groups, such as foetuses and pregnant women, may be exposed to harmful combinations of chemicals that include PFAS. However, the role environmental exposures play in reproductive disorders has received little attention by the medical community. To better understand the potential risk of PFAS on human ovarian function, additional experimental studies using PFAS doses equivalent to the exposure levels found in the general human population and mixtures of compounds are required. Prospective investigations in human populations are also warranted to ensure the temporality of PFAS exposure and health endpoints and to minimise the possibility of reverse causality.

Abstract Image

Abstract Image

Abstract Image

全氟烷基和多氟烷基物质及其对卵巢的影响。
背景:全氟烷基和多氟烷基物质(PFAS)广泛存在于饮用水、食品、食品包装材料和其他消费品中。基于它们干扰正常生殖功能和激素信号的能力,几种PFAS已被确定为内分泌干扰化学物质。实验模型和流行病学研究表明,PFAS暴露的目标是卵巢,是妇女健康的主要风险。目的与理由:本文综述了PFAS暴露与卵巢功能之间的人群和毒理学研究。检索方法:通过检索PubMed进行全面的综述。搜索词包括广泛的PFAS和健康术语列表,从一般关键词(如卵巢,生殖,卵泡,卵母细胞)到特定关键词(包括月经初潮,月经周期,更年期,原发性卵巢功能不全/卵巢早衰,类固醇激素),基于作者对主题和关键词的了解。结果:临床证据表明PFAS存在于卵泡液中,并具有通过血液-卵泡屏障的能力。尽管一些研究没有发现PFAS暴露与卵巢功能破坏相关的证据,但许多流行病学研究(大多采用横断面研究设计)已经确定,PFAS暴露较高与月经初潮推迟、月经周期不规则、周期长度延长、绝经年龄提前以及雌激素和雄激素水平降低有关。PFAS对卵巢卵泡生成和类固醇生成的不良影响已在实验模型中得到证实。根据实验室研究发现,PFAS可通过激活过氧化物酶体增殖体激活受体、破坏卵母细胞与颗粒细胞之间的间隙连接细胞间通讯、诱导甲状腺激素缺乏、拮抗卵巢甾体生成相关的卵巢酶活性或抑制下丘脑kisspeptin信号传导,从而降低卵巢储备,减少内源性激素合成。更广泛的影响:已发表的文献支持PFAS暴露与不良生殖结果之间的关联;然而,证据仍然不足以推断PFAS暴露与卵巢疾病之间的因果关系。因此,有必要进行更多的研究。PFAS是一个值得关注的重大问题,因为这些化学物质在环境和人类中普遍存在并持续存在。此外,易感群体,如胎儿和孕妇,可能会接触到包括PFAS在内的有害化学物质组合。然而,环境暴露在生殖障碍中的作用很少受到医学界的关注。为了更好地了解PFAS对人类卵巢功能的潜在风险,需要使用相当于一般人群和化合物混合物暴露水平的PFAS剂量进行额外的实验研究。还需要对人群进行前瞻性调查,以确保PFAS暴露的临时性和健康终点,并尽量减少反向因果关系的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human Reproduction Update
Human Reproduction Update 医学-妇产科学
CiteScore
28.80
自引率
1.50%
发文量
38
期刊介绍: Human Reproduction Update is the leading journal in its field, boasting a Journal Impact FactorTM of 13.3 and ranked first in Obstetrics & Gynecology and Reproductive Biology (Source: Journal Citation ReportsTM from Clarivate, 2023). It specializes in publishing comprehensive and systematic review articles covering various aspects of human reproductive physiology and medicine. The journal prioritizes basic, transitional, and clinical topics related to reproduction, encompassing areas such as andrology, embryology, infertility, gynaecology, pregnancy, reproductive endocrinology, reproductive epidemiology, reproductive genetics, reproductive immunology, and reproductive oncology. Human Reproduction Update is published on behalf of the European Society of Human Reproduction and Embryology (ESHRE), maintaining the highest scientific and editorial standards.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书